Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma

다국어 초록 (Multilingual Abstract)

Hepatitis B virus (HBV) has an important role in the development of human hepatocellular carcinoma (HCC). Accumulated evidence has shown that HBV-encoded X protein (HBx) can induce both genetic alterations in tumor suppressor genes and oncogenes, as well as epigenetic aberrations in HCC pathogens. Non-coding RNAs (ncRNAs) mainly include microRNAs and long non-coding RNAs (lncRNAs). Although ncRNAs cannot code proteins, growing evidence has shown that they have various important biological functions in cell proliferation, cell cycle control, anti-apoptosis, epithelial–mesenchymal transition, tumor invasion and metastasis. This review summarizes the current knowledge regarding the mechanisms and emerging roles of ncRNAs in the pathogenesis of HBV-related HCC. Accumulated data have shown that ncRNAs regulated by HBx have a crucial role in HBV-associated hepatocarcinogenesis. The findings of these studies will contribute to more clinical applications of HBV-related ncRNAs as potential diagnostic markers or as molecular therapeutic targets to prevent and treat HBV-related HCC.

참고문헌 (Reference)

1 Sánchez-Tilló E, "β-catenin/TCF4 complex induces the epithelial-tomesenchymal transition(EMT)-activator ZEB1 to regulate tumor invasiveness" 108 : 19204-19209, 2011

2 Shiseki M, "p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity" 63 : 2373-2378, 2003

3 Chen WS, "miRNA--7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin" 6 : 25962-25974, 2015

4 Toffanin S, "miRNA delivery : emerging therapy for hepatocellular carcinoma" 138 : 1202-1204, 2010

5 Fu X, "miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 30-UTR region of CyclinD1" 13 : 8514-8539, 2012

6 Galardi S, "miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1" 282 : 23716-23724, 2007

7 Jiang R, "miR-22 promotes HBV-related hepatocellular carcinoma development in males" 17 : 5593-5603, 2011

8 Wei X, "miR-101 is downregulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A" 25 : 439-446, 2013

9 Diao J, "X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis" 12 : 189-205, 2001

10 Lau CC, "Viral-human chimeric transcript predisposes risk to liver cancer development and progression" 25 : 335-349, 2014

11 Grillo M, "Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7breast cancer cells : effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression" 95 : 185-194, 2006

12 Van Dort C, "VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways" 285 : C1386-C1396, 2003

13 Kong G, "Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model" 6 : e19518-, 2011

14 Cao Y, "Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5" 6 : 38093-38106, 2015

15 Zhang X, "Up-regulated microRNA-143transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression" 50 : 490-499, 2009

16 Cengiz B, "Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma" 127 : 2088-2094, 2010

17 Bandopadhyay M, "Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes" 14 : 721-, 2014

18 Struhl K, "Transcriptional noise and the fidelity of initiation by RNA polymerase II" 14 : 103-105, 2007

19 Whittaker S, "The role of signaling pathways in the development and treatment of hepatocellular carcinoma" 29 : 4989-5005, 2010

20 Li B, "The role of chromatin during transcription" 128 : 707-719, 2007

21 Zhao Q, "The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression" 9 : e109782-, 2014

22 Lara-Pezzi E, "The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression" 110 : 1831-1838, 2002

23 Terradillos O, "The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice" 14 : 395-404, 1997

24 Park BJ, "The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR" 120 : 209-221, 2005

25 Ambros V, "The functions of animal microRNAs" 431 : 350-355, 2004

26 Xing YN, "The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression" 42 : 25-35, 2011

27 Matouk IJ, "The H19 non-coding RNA is essential for human tumor growth" 2 : e845-, 2007

28 Meloche S, "The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition" 26 : 3227-3239, 2007

29 Hussain SP, "TP53 mutations and hepatocellular carcinoma : insights into the etiology and pathogenesis of liver cancer" 26 : 2166-2176, 2007

30 Bui-Nguyen TM, "Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator" 285 : 6980-6986, 2010

31 Moazed D, "Small RNAs in transcriptional gene silencing and genome defence" 457 : 413-420, 2009

32 Malone CD, "Small RNAs as guardians of the genome" 136 : 656-668, 2009

33 McCubrey JA, "Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance" 46 : 249-279, 2006

34 Yuan K, "Role of miR-148a in hepatitis B associated hepatocellular carcinoma" 7 : e35331-, 2012

35 le Sage C, "Regulation of the p27(Kip1)tumor suppressor by miR-221 and miR-222promotes cancer cell proliferation" 26 : 3699-3708, 2007

36 Bar-Peled L, "Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1" 150 : 1196-1208, 2012

37 Hämmerle M, "Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1(IGF2BP1)" 58 : 1703-1712, 2013

38 Lu JW, "Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway" 9 : e85318-, 2014

39 Carthew RW, "Origins and Mechanisms of miRNAs and siRNAs" 136 : 642-655, 2009

40 Nana-Sinkam SP, "Non-coding RNAs in cancer initiation and progression and as novel biomarkers" 5 : 483-491, 2011

41 Tommasi S, "Molecular pathways and related target therapies in liver carcinoma" 13 : 3279-3287, 2007

42 Min L, "Mitogen-activated protein kinases in hepatocellular carcinoma development" 21 : 10-20, 2011

43 Fu M, "Minireview : cyclin D1 : normal and abnormal functions" 145 : 5439-5447, 2004

44 Giordano S, "MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?" 57 : 840-847, 2013

45 Bartel DP., "MicroRNAs: genomics, biogenesis, mechanism, and function" 116 : 281-297, 2004

46 Lee YS, "MicroRNAs in cancer" 4 : 199-227, 2009

47 Fu LL, "MicroRNA-modulated autophagic signaling networks in cancer" 44 : 733-736, 2012

48 Yang L, "MicroRNA-602regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma" 9 : 803-808, 2010

49 Hu XM, "MicroRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein HBXIP" 46 : 804-815, 2016

50 Dong Q, "MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2" 5 : e10147-, 2010

51 Barh D, "MicroRNA let-7 : an emerging next-generation cancer therapeutic" 17 : 70-80, 2010

52 Liu FY, "MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway" 6 : e1670-, 2015

53 Cui M, "MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1(ACSL1)mRNA" 444 : 270-275, 2014

54 Meister G, "Mechanisms of gene silencing by doublestranded RNA" 431 : 343-349, 2004

55 Woessner JF Jr, "Matrix metalloproteinases and their inhibitors in connective tissue remodeling" 5 : 2145-2154, 1991

56 Wilusz JE, "Long noncoding RNAs : functional surprises from the RNA world" 23 : 1494-1504, 2009

57 Kogo R, "Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers" 71 : 6320-6326, 2011

58 Mercer TR, "Long non-coding RNAs : insights into functions" 10 : 155-159, 2009

59 Gupta RA, "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis" 464 : 1071-1076, 2010

60 Yoon JH, "LincRNA-p21 suppresses target mRNA translation" 47 : 648-655, 2012

61 Wu G, "Lin28B over-expression mediates the repression of let-7 by hepatitis B virus X protein in hepatoma cells" 8 : 15108-15116, 2015

62 Liu D, "Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways" 13 : 828-839, 2012

63 Wang Y, "Lethal-7 is downregulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3" 53 : 57-66, 2010

64 Slagle BL, "Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene" 15 : 261-269, 1996

65 Hou J, "Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR--199a/b-3p as therapeutic target for hepatocellular carcinoma" 19 : 232-243, 2011

66 Budhu A, "Identification of metastasis-related microRNAs in hepatocellular carcinoma" 47 : 897-907, 2008

67 Wang W, "Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma" 18 : 5442-5453, 2012

68 Ohata H, "Identification of a function-specific mutation of clathrin heavy chain(CHC)required for p53 transactivation" 394 : 460-471, 2009

69 Yin C, "Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region" 58 : 1964-1976, 2013

70 Liang HW, "Hepatitis B virushuman chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122" 64 : 278-291, 2016

71 Chen YJ, "Hepatitis B virus-encoded X protein downregulates EGFR expression via inducing microRNA-7 in hepatocellular carcinoma cells" 2013 : 682380-, 2013

72 Kew MC, "Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma" 26 : 144-152, 2011

73 Arbuthnot P, "Hepatitis B virus and hepatocellular carcinoma" 82 : 77-100, 2001

74 Tian Y, "Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis" 33 : 2810-2816, 2013

75 Huang JF, "Hepatitis B virus X protein(HBx)-related long noncoding RNA(lncRNA)downregulated expression by HBx(Dreh)inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin" 57 : 1882-1892, 2013

76 You X, "Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells" 34 : 1644-1652, 2013

77 Xu X, "Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis" 123 : 630-645, 2013

78 Li CH, "Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression" 50 : 2560-2569, 2014

79 Zhang T, "Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis" 15 : 1282-1291, 2013

80 Yu DH, "Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways" 29 : 1089-1093, 2009

81 Wu G, "Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro" 105 : 146-153, 2011

82 Zhang XD, "Hepatitis B virus X protein accelerates the development of hepatoma" 11 : 182-190, 2014

83 Zhang W, "Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP" 13 : 128-, 2014

84 Wang Y, "Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes" 288 : 18484-18493, 2013

85 Hu JJ, "HBxupregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling" 6 : 23521-, 2016

86 Huang JL, "HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma" 6 : 33791-33804, 2015

87 Qiu X, "HBx-mediated miR-21upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma" 32 : 3296-3305, 2013

88 Zhu R, "HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter" 26 : 23-35, 2011

89 Chen JJ, "HBx proteininduced upregulation of microRNA-221 promotes aberrant proliferation in HBV-related hepatocellular carcinoma by targeting estrogen receptor-α" 33 : 792-798, 2015

90 Kuo CY, "HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3beta/beta-catenin cascade" 51 : 130-136, 2008

91 Zhao J, "HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes" 33 : 715-722, 2014

92 Nault JC, "Genetics of hepatobiliary carcinogenesis" 31 : 173-187, 2011

93 Nishida N, "Genetic and epigenetic signatures in human hepatocellular carcinoma : a systematic review" 12 : 130-137, 2011

94 Naugler WE, "Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production" 317 : 121-124, 2007

95 Iwatsuki M, "Epithelial-mesenchymal transition in cancer development and its clinical significance" 101 : 293-299, 2010

96 Herceg Z, "Epigenetics and cancer : towards an evaluation of the impact of environmental and dietary factors" 22 : 91-103, 2007

97 Wei X, "Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma" 25 : 1037-1043, 2013

98 Arzumanyan A, "Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer" 31 : 563-572, 2012

99 Song K, "Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptorgamma and hepatitis b virus X protein in hepatocellular carcinoma cells" 58 : 1681-1692, 2013

100 Zheng DL, "Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A" 50 : 377-387, 2009

101 Herceg Z, "Epigenetic mechanisms in hepatocellular carcinoma : how environmental factors influence the epigenome" 727 : 55-61, 2011

102 Vaissière T, "Epigenetic interplay between histone modifications and DNA methylation in gene silencing" 659 : 40-48, 2008

103 Sawan C, "Epigenetic drivers and genetic passengers on the road to cancer" 642 : 1-13, 2008

104 Kew MC., "Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma" 58 : 273-277, 2010

105 Du Y, "Elevation of highly up-regulated in liver cancer(HULC)by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18" 287 : 26302-26311, 2012

106 Xiong Y, "Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma" 51 : 836-845, 2010

107 Imoto M, "Effects of cyclin D1overexpression on G1 progression-related events" 236 : 173-180, 1997

108 Gao F, "Downregulation of microrna-145caused by hepatitis B virus X protein promotes expression of CUL5 and contributes to pathogenesis of hepatitis B virus-associated hepatocellular carcinoma" 37 : 1547-1559, 2015

109 Wu CS, "Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression" 134 : 1638-1647, 2014

110 Huang J, "Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1" 52 : 60-70, 2010

111 Borel F, "Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma" 56 : 1371-1383, 2012

112 Li X, "Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma" 136 : 1573-1583, 2010

113 Lopez-Serra P, "DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer" 31 : 1609-1622, 2012

114 Tischoff I, "DNA methylation in hepatocellular carcinoma" 14 : 1741-1748, 2008

115 Baylin SB, "DNA methylation and gene silencing in cancer" 2 (2): S4-S11, 2005

116 Gramantieri L, "Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma" 67 : 6092-6099, 2007

117 Melegari M, "Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication" 72 : 1737-1743, 1998

118 Chu CJ, "Clinical significance of hepatitis B virus genotypes" 35 : 1274-1276, 2002

119 Chen X, "Characterization of microRNAs in serum : a novel class of biomarkers for diagnosis of cancer and other diseases" 18 : 997-1006, 2008

120 Panzitt K, "Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA" 132 : 330-342, 2007

121 Malumbres M, "Cell cycle, CDKs and cancer: a changing paradigm" 9 : 153-166, 2009

122 Lin J, "Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence" 20 : 2000-2009, 2001

123 Yip WK, "Carboxylterminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development" 6 : e22888-, 2011

124 Siegel R, "Cancer statistics2014" 64 : 9-29, 2014

125 Wang J, "CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer" 38 : 5366-5383, 2010

126 Bonelli P, "CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity" 2014 : 361020-, 2014

127 Sherr CJ, "CDK inhibitors : positive and negative regulators of G1-phase progression" 13 : 1501-1512, 1999

128 Polette M, "Beta-catenin and ZO-1 : shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes" 185 : 61-65, 2007

129 Edamoto Y, "Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis" 106 : 334-341, 2003

130 Park IY, "Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein" 132 : 1476-1494, 2007

131 Johnsson P, "A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells" 20 : 440-446, 2013

132 Lin R, "A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas" 26 : 851-858, 2007